Lokelma drug classification?

What class is Lokelma (sodium zirconium cyclosilicate) considered?

Lokelma is classified as a sodium zirconium cyclosilicate therapy used to treat hyperkalemia (high potassium). It works by binding potassium in the gastrointestinal tract and increasing its elimination through the stool [1].

What does Lokelma bind, and how is that tied to its drug classification?

Lokelma is a potassium binder. Its main pharmacologic action is selective potassium adsorption in the gut, which lowers blood potassium levels [1].

Is Lokelma an antidiuretic, diuretic, or something else?

No. Lokelma is not a diuretic or an antidiuretic. Its potassium-lowering effect comes from binding potassium in the digestive tract rather than changing kidney water or sodium handling [1].

What condition is Lokelma classified for?

Lokelma is used for the treatment of hyperkalemia, including in settings where clinicians need to reduce potassium levels safely and maintain normal potassium [1].

Sources

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/